Quick Overview:
Telmisartan is an Angiotensin II Receptor Blocker (ARB). It selectively blocks the binding of angiotensin II to the $AT_1$ receptor subtype in vascular smooth muscles, preventing widespread vasoconstriction (narrowing) and aldosterone release. This causes arteries to relax and widen, easing blood flow.
Hydrochlorothiazide is a thiazide diuretic ("water pill"). It promotes the excretion of excess sodium, chloride, and water through the kidneys into urine, effectively reducing total circulating blood volume and lowering fluid pressure against vessel walls.
No description available.
Uses / Indications
Essential Hypertension: Management of high blood pressure when monotherapy (a single agent) is insufficient to achieve targeted glycemic or vascular control.
Cardiovascular Risk Reduction: Minimizes long-term systemic risks of structural cardiovascular events like strokes, heart failure, and myocardial infarctions (heart attacks).
Key Benefits
Sustained 24-Hour Control: Telmisartan's exceptionally long elimination half-life provides continuous blood pressure management, successfully blunting early morning hypertensive surges.
Synergistic Efficacy: Provides a more robust reduction in blood pressure with fewer dose-dependent side effects than maximal doses of either component taken independently.
Target Organ Protection: Slows down pressure-related microvascular and macrovascular strain, preserving kidney function and reducing the likelihood of heart attacks.
As Directed by a Physician: Typically administered as one tablet orally once per day.
Dizziness or lightheadedness (especially when rising rapidly from a sitting or lying position)
Fatigue, physical weakness (asthenia), or tiredness
Nausea, diarrhea, or mild abdominal discomfort
Upper respiratory tract infections or sinusitis
- Store in a cool dry place
- Keep away from direct sunlight
- Keep out of reach of children
- Read the label carefully before use
